Further reading
Read the records behind the care questions
Find the record that fits your question. Each link opens material used for the journal’s notes.
Drugs and how they are made
- FDA application records
The drug-approval records behind the named products and the approval searches.
This source was checked on September 26, 2026.
- Why a pharmacy might mix or change a medicine
The FDA explains compounding: mixing or changing ingredients to meet a patient’s need.
This source was checked on September 26, 2026.
- FDA on the quality of medicines mixed to order
What the FDA does not check before sale, and what can go wrong when a medicine is poorly made.
This source was checked on September 26, 2026.
- FDA’s safety concerns about peptide ingredients
Look here for risks and for requests to allow ingredients that were later taken back. Being in the withdrawn-request table does not mean an ingredient was cleared.
This source was checked on September 26, 2026.
- Which ingredients fall under FDA’s temporary action policy?
For ordinary compounding pharmacies, this document groups ingredients by how the FDA plans to act while it reviews them. It is not a list of approved medicines or a promise that a pharmacy may legally make one for you.
This source was checked on September 26, 2026.
- FDA’s summer advisory meeting record
The meeting material behind the note on advisory discussions.
This source was checked on September 26, 2026.
- FDA’s shortage and copy-policy updates
The dated updates behind the national shortage distinction.
This source was checked on September 26, 2026.
- FDA on unapproved weight medicines
Concerns about pharmacy-made medicines and products sold for treatment with labels saying they are only for research.
This source was checked on September 26, 2026.
- FDA on advertising medicines mixed by pharmacies
Read this when an offer claims approval, says a mixed medicine is the same as an approved one, or makes claims about who supplies it.
This source was checked on September 26, 2026.
Care and public records
- Medical boards’ suggested policy for online care
Guidance for medical boards; this is not a law applying across the country.
This source was checked on September 26, 2026.
- Find the board for a doctor’s record
Use the directory to reach the board holding the doctor’s public record.
This source was checked on September 17, 2026.
- FDA links to pharmacy licence searches
Choose the state board and check the pharmacy’s name there.
This source was checked on September 17, 2026.
- Medical boards’ consumer information
How to read licensing and public disciplinary information.
This source was checked on September 17, 2026.
- FTC on online health offers
Why an official-looking seal is not enough to assess an offer.
This source was checked on September 17, 2026.
Costs and Medicare access
- Medicare’s temporary Bridge program
The program overview and patient payment terms.
This source was checked on September 26, 2026.
- Bridge eligibility and product details
The full health, plan and prior-approval requirements for a prescriber to review.
This source was checked on September 26, 2026.
- Bridge payment rules for drug plans
How Bridge prescriptions are paid through a separate process from normal Part D drug coverage.
This source was checked on September 26, 2026.
- Medicare’s patient page on weight medicines
A patient-facing account of the program.
This source was checked on September 26, 2026.
- Government-listed semaglutide offer
The introductory and later self-pay terms; match the product and offer conditions.
This source was checked on September 26, 2026.
Help and problem reports
- MedlinePlus on severe allergic reactions
The urgent-help signs and emergency advice used in the help note.
This source was checked on September 17, 2026.
- MedWatch reporting
The FDA program for reporting a suspected medicine problem.
This source was checked on September 17, 2026.
- What reports of medicine problems can tell you
Help with reading the FDA’s online display of reports other people have sent. It does not prove what caused a problem or how likely it is; use the MedWatch link above to send a report.
This source was checked on September 17, 2026.
- FDA alert on semaglutide dosing errors
Why unclear medicine measurements can cause harm; take questions about your own instructions to the person prescribing it.
This source was checked on September 26, 2026.
Competitive sport rules
- WADA’s list of banned substances in sport
The World Anti-Doping Agency’s list in force when these notes were checked. Read which substances each group covers, beyond the named examples.
This source was checked on September 26, 2026.
- WADA’s published replacement list
Check the effective date before applying its wording.
This source was checked on September 26, 2026.
- WADA’s notes on tracking substance use in sport
Monitoring means tracking use to watch for misuse; it does not itself ban a substance.
This source was checked on September 26, 2026.
- How to seek permission for a medically needed banned drug
USADA, the US anti-doping body, explains medical exemptions. Athletes in its named testing groups need permission in advance; others are directed to a form to check what they need before using the medicine.
This source was checked on September 17, 2026.
- The NCAA’s college-sport list
A separate rule set for college competition.
This source was checked on September 26, 2026.
Read what a record can establish
A licence record shows whether the person treating you is licensed and whether public disciplinary action is recorded; it does not rate the quality of their care.
A suspected-problem report does not establish cause or measure the chance of a problem.
Take questions about your own care to the person treating you. Keep the exact product name and the proposed use beside anything you read.